Stock listing

ASX:BDX BCAL Diagnostics Limited Share Price

Follow BCAL Diagnostics Limited into a list and get an email when it puts out news.

Share price · ASX:BDX

$0.079 AUD 0.000 (0.0%)

Close on Oct 16, 2026

BCAL Diagnostics Limited logo
Ticker
ASX:BDX
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
ASX
Currency
AUD

What changed lately

Latest news

BREASTESTplus 2 clinically validated

Sep 29, 2026

BCAL Introduces Avantect Multi-Cancer Early Detection Test

Sep 22, 2026

Appendix 4E and Annual Report to shareholders

Aug 28, 2026

BCAL Takes Interest in Genetic Signatures to 18.46%

Aug 25, 2026

BCAL Secures Funding for FY2027 Update

Aug 21, 2026

BCAL to Acquire Shares in Genetic Signatures

Jul 1, 2026

BCAL Secures Funding for FY2027

Jun 28, 2026

BCAL Develops New Blood Test for Breast Cancer Recurrence

Jun 17, 2026

BCAL Launches Early Detection Cancer Platform

May 19, 2026

BCAL Appoints Anne-Louise Arnett as Chief Executive Officer

May 10, 2026

All BCAL Diagnostics Limited news

Decks

BCAL Diagnostics Limited on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
17 in the last 12 months · 46 in all · newest Sep 29, 2026 · oldest 2021
Decks
18 decks · latest October 2026

Log in to ask 6ix AI your own questions about BCAL Diagnostics Limited.